UNSPSC 51292106: Maprotiline hydrochloride

This classification denotes a tricyclic antidepressant with the molecular formula C20H23N.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7C8J54PVFI, chemically known as 9,10-ethanoanthracene-9(10h)-propylamine, n-methyl-, hydrochloride but more generally known as maprotiline hydrochloride, which bears US NIH Compound Identifier 71478. European Medicines Agency schedules Maprotiline hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB03088MIG.

UNSPSC 51292106 Maprotiline hydrochloride, a Commodity code, shows no recent state and local procurement activity aligned with its nominal scope. The single recent opportunity tagged to this code — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023 — solicits Naloxone and Safe Drug Deactivation Systems, which fall outside the pharmaceutical antidepressant category this code describes. The mismatch suggests either a classification error in the source data or a narrow technical application of the code not reflected in current buying patterns. Without additional opportunities demonstrating legitimate demand for maprotiline hydrochloride through state and local channels, this code presents limited visibility into active market activity.

No representative recent opportunities in the source material align with the code's stated commodity. Prospective vendors should monitor procurement channels in Florida and other states for any corrected or future solicitations under this code, but current signals do not support active pursuit based on recent state and local activity alone.